D.E. Shaw & Co
TSHA icon

D.E. Shaw & Co’s Taysha Gene Therapies TSHA Stock Holding History

D.E. Shaw & Co’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.8M Buy
4,427,301
+413,666
+10% +$1.92M 0.01% 1151
2025
Q4 		$22.1M Buy
4,013,635
+1,307,201
+48% +$6.35M 0.01% 1190
2025
Q3 		$8.85M Buy
2,706,434
+2,304,925
+574% +$6.53M 0.01% 1787
2025
Q2 		$927K Buy
+401,509
New +$872K ﹤0.01% 3288
2022
Q4 		– Sell
-107,274
Closed -$207K – 5132
2022
Q3 		$207K Sell
107,274
-27,311
-20% -$99.1K ﹤0.01% 4465
2022
Q2 		$501K Buy
134,585
+59,851
+80% +$237K ﹤0.01% 4086
2022
Q1 		$487K Buy
+74,734
New +$559K ﹤0.01% 4383
2021
Q3 		– Sell
-11,448
Closed -$243K – 5245
2021
Q2 		$243K Buy
+11,448
New +$264K ﹤0.01% 4373

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM